Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Kheloussi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The American Journal of Managed Care|April 27, 2023
Prior authorization requirements for calcitonin gene-related peptide antagonistsLindsay Musial, Steven Kheloussi
Journal of Managed Care & Specialty Pharmacy|May 29, 2026
Patient experience data in formulary decision-making: Payer-reported perceptions and useSteven Kheloussi, Iyar Mazar, Magdalena Harrington, et al.
Journal of Managed Care & Specialty Pharmacy|September 20, 2022
Clinical and economic impact of long-acting injectable antipsychotics in patients previously treated with short-acting oral antipsychoticsSteven Kheloussi, John Oberlin, Madison Trauger, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
Cost and clinical impact of a nonmedical DPP-4 inhibitor switch in patients with diabetesSteven Kheloussi, Alicia Johns, Vincenzo Parente, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The American Journal of Managed Care|April 27, 2023
Prior authorization requirements for calcitonin gene-related peptide antagonistsLindsay Musial, Steven Kheloussi
Journal of Managed Care & Specialty Pharmacy|May 29, 2026
Patient experience data in formulary decision-making: Payer-reported perceptions and useSteven Kheloussi, Iyar Mazar, Magdalena Harrington, et al.
Journal of Managed Care & Specialty Pharmacy|September 20, 2022
Clinical and economic impact of long-acting injectable antipsychotics in patients previously treated with short-acting oral antipsychoticsSteven Kheloussi, John Oberlin, Madison Trauger, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
Cost and clinical impact of a nonmedical DPP-4 inhibitor switch in patients with diabetesSteven Kheloussi, Alicia Johns, Vincenzo Parente, et al.
Pageof 1